Effect of Rifampin on the Pharmacokinetics of Apixaban, an Oral Direct Inhibitor of Factor Xa

被引：0
|
作者：
Blisse Vakkalagadda
Charles Frost
Wonkyung Byon
Rebecca A. Boyd
Jessie Wang
Donglu Zhang
Zhigang Yu
Clapton Dias
Andrew Shenker
Frank LaCreta
机构：
[1] Bristol-Myers Squibb Company,Research and Development, Discovery Medicine and Clinical Pharmacology
[2] Pfizer Inc,Global Innovative Pharma Business Clinical Pharmacology
[3] Bristol-Myers Squibb Company,Global Biometric Sciences
[4] Bristol-Myers Squibb Company,Pharmaceutical Candidate Optimization
来源：
American Journal of Cardiovascular Drugs | 2016年 / 16卷
关键词：
Rifampin; Apixaban; Breast Cancer Resistance Protein; Absolute Oral Bioavailability; Single Ascend Dose Study;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：119 / 127
页数：8
相关论文
共 50 条
  • [21] Apixaban, an oral direct factor Xa inhibitor, inhibits human clot-bound factor Xa activity in vitro
    Jiang, Xiaosui
    Crain, Earl J.
    Schumacher, William A.
    Wong, Pancras C.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (06) : E137 - E137
  • [22] Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor Xa inhibitor, in healthy subjects
    Frost, Charles
    Nepal, Sunil
    Wang, Jessie
    Schuster, Alan
    Byon, Wonkyung
    Boyd, Rebecca A.
    Yu, Zhigang
    Shenker, Andrew
    Barrett, Yu Chen
    Mosqueda-Garcia, Rogelio
    LaCreta, Frank
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 76 (05) : 776 - 786
  • [23] Effect of the Direct Factor Xa Inhibitor Apixaban in Rat Models of Thrombosis and Hemostasis
    Schumacher, William A.
    Bostwick, Jeffrey S.
    Stewart, Anne B.
    Steinbacher, Thomas E.
    Xin, Baomin
    Wong, Pancras C.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2010, 55 (06) : 609 - 616
  • [24] Effect of food on the pharmacokinetics of darexaban, an oral direct factor Xa inhibitor, in healthy Japanese subjects
    Kadokura, Takeshi
    Taniuchi, Yuta
    Inoue, Hiroshi
    Saito, Masako
    Iwahana, Mioko
    Yamada, Shunsuke
    Urae, Akinori
    Nakamura, Mashio
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2013, 51 (03) : 200 - 206
  • [25] EFFECT OF APIXABAN, AN ORAL, DIRECT AND SELECTIVE FACTOR XA INHIBITOR ON INFLAMMATORY BIOMARKERS FOLLOWING ACUTE CORONARY SYNDROME
    Becker, Richard C.
    Lin, Annie
    Yang, Hongqiu
    Barrett, Yuchen
    Mohan, Puneet
    Wang, Jessie
    Alexander, John
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E1039 - E1039
  • [26] Effect of apixaban, an oral and direct factor Xa inhibitor, on coagulation activity biomarkers following acute coronary syndrome
    Becker, Richard C.
    Alexander, John H.
    Newby, L. Kristin
    Yang, Hongqiu
    Barrett, Yuchen
    Mohan, Puneet
    Wang, Jessie
    Harrington, Robert A.
    Wallentin, Lars C.
    THROMBOSIS AND HAEMOSTASIS, 2010, 104 (05) : 976 - 983
  • [27] Preclinical pharmacokinetics and pharmacodynamics of apixaban, a potent and selective factor Xa inhibitor
    Kan He
    Joseph M. Luettgen
    Donglu Zhang
    Bing He
    James E. Grace
    Baomin Xin
    Donald J. P. Pinto
    Pancras C. Wong
    Robert M. Knabb
    Patrick Y. S. Lam
    Ruth R. Wexler
    Scott J. Grossman
    European Journal of Drug Metabolism and Pharmacokinetics, 2011, 36 : 129 - 139
  • [28] Chromogenic laboratory assays to measure the factor Xa-inhibiting properties of apixaban—an oral, direct and selective factor Xa inhibitor
    Richard C. Becker
    Hongqiu Yang
    Yuchen Barrett
    Puneet Mohan
    Jessie Wang
    Lars Wallentin
    John H. Alexander
    Journal of Thrombosis and Thrombolysis, 2011, 32 : 183 - 187
  • [29] Preclinical pharmacokinetics and pharmacodynamics of apixaban, a potent and selective factor Xa inhibitor
    He, Kan
    Luettgen, Joseph M.
    Zhang, Donglu
    He, Bing
    Grace, James E., Jr.
    Xin, Baomin
    Pinto, Donald J. P.
    Wong, Pancras C.
    Knabb, Robert M.
    Lam, Patrick Y. S.
    Wexler, Ruth R.
    Grossman, Scott J.
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2011, 36 (03) : 129 - 139
  • [30] Apixaban, an oral, direct and highly selective factor Xa inhibitor:: in vitro, antithrombotic and antihemostatic studies
    Wong, P. C.
    Crain, E. J.
    Xin, B.
    Wexler, R. R.
    Lam, P. Y. S.
    Pinto, D. J.
    Luettgen, J. M.
    Knabb, R. M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2008, 6 (05) : 820 - 829
12345